Dermapharm Holding SE (DMP) — Cash Flow Reinvestment Rate
Dermapharm Holding SE (DMP) has a Cash Flow Reinvestment Rate of 0.30x as of March 2026, reinvesting €11.85 Million (capex €11.85 Million ) from operating cash flow of €39.49 Million. Check Dermapharm Holding SE earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dermapharm Holding SE Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Dermapharm Holding SE across 12 annual periods. Explore DMP long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Dermapharm Holding SE (2014–2025)
Year-by-year capital reinvestment analysis for Dermapharm Holding SE. For live market cap and broader valuation context, see DMP market cap overview.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | €51.93 Million | €181.51 Million | €42.12 Million | ▼ -15.1% |
| 2024 | 0.34x | €67.85 Million | €201.38 Million | €38.24 Million | ▼ -83.8% |
| 2023 | 2.08x | €456.97 Million | €219.42 Million | €41.54 Million | ▲ +335.4% |
| 2022 | 0.48x | €138.02 Million | €288.53 Million | €39.01 Million | ▲ +9.4% |
| 2021 | 0.44x | €109.46 Million | €250.37 Million | €61.20 Million | ▲ +30.5% |
| 2020 | 0.34x | €43.93 Million | €131.10 Million | €40.80 Million | ▼ -68.3% |
| 2019 | 1.06x | €106.29 Million | €100.61 Million | €46.44 Million | ▲ +542.0% |
| 2018 | 0.16x | €26.18 Million | €159.13 Million | €25.97 Million | ▼ -80.9% |
| 2017 | 0.86x | €74.75 Million | €86.74 Million | €74.72 Million | ▲ +271.7% |
| 2016 | 0.23x | €17.80 Million | €76.78 Million | €17.76 Million | ▼ -54.8% |
| 2015 | 0.51x | €20.70 Million | €40.38 Million | €14.93 Million | ▼ -18.6% |
| 2014 | 0.63x | €34.19 Million | €54.26 Million | €28.42 Million | — |